Human opsonins to meningococci after vaccination

Area of Science:

• Immunology
• Microbiology
• Vaccinology

Background:

• Neisseria meningitidis causes serious infections, with serogroups A, B, and C being major concerns.
• Effective vaccines are crucial for preventing meningococcal disease outbreaks.

Purpose of the Study:

• To evaluate the immunogenicity of meningococcal polysaccharide and protein-based vaccines.
• To assess serum opsonin responses against various Neisseria meningitidis serogroups.

Main Methods:

• Volunteers received either a serogroup A plus C polysaccharide vaccine or a combined serogroup B polysaccharide-protein vaccine.
• Serum opsonin levels were quantified using chemiluminescence assays with polymorphonuclear leukocytes and live meningococci.

Main Results:

• The A plus C vaccine elicited opsonin responses in some recipients against serogroup A and C meningococci.
• The combined B vaccine induced significant opsonin responses against two protein serotypes of group B and a group C strain.
• No booster effect was observed after a second dose of the combined vaccine.

Conclusions:

• Both polysaccharide and protein components of the tested vaccines can stimulate opsonin production.
• The combined serogroup B vaccine demonstrated efficacy in generating protective antibodies against relevant meningococcal strains.